| 2026-02-27 | +26.1% | earnings | GuruFocus.com | Compugen Ltd (CGEN) Q4 2025: Everything You Need To Know Ahead Of Earnings |
| 2026-02-27 | +26.1% | earnings | Seeking Alpha | Compugen Q4 2025 Earnings Preview |
| 2026-02-27 | +26.1% | earnings | TradingView | Compugen Ltd expected to post earnings of 5 cents a share - Earnings Preview - TradingView |
| 2024-05-17 | -19.0% | earnings | Seeking Alpha | Compugen Q1 2024 Earnings Preview |
| 2024-05-20 | -12.2% | earnings | Seeking Alpha | Compugen Ltd. (CGEN) Q1 2024 Earnings Call Transcript |
| 2024-05-20 | -12.2% | earnings | Seeking Alpha | Compugen GAAP EPS of -$0.08 beats by $0.03, revenue of $2.56M beats by $1.35M |
| 2026-04-09 | +12.2% | news | PR Newswire | Compugen to Participate in 25th Annual Needham Virtual Healthcare Conference |
| 2026-04-09 | +12.2% | news | Stock Titan | Compugen management takes virtual Needham healthcare stage April 13 - Stock Titan |
| 2026-04-09 | +12.2% | news | Stock Titan | Compugen (CGEN) SVP exercises options and sells 7,875 Ordinary Shares - Stock Titan |
| 2026-04-09 | +12.2% | news | Cổng thông tin điện tử tỉnh Tây Ninh | What is the long-term potential of Compugen (CGEN) Stock | Price at $2.46, Up 7.42% - Risk Management - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-03-02 | +11.3% | earnings | Moby | Compugen Ltd. Q4 2025 Earnings Call Summary |
| 2026-03-02 | +11.3% | earnings | Zacks | Compugen (CGEN) Beats Q4 Earnings and Revenue Estimates |
| 2026-03-02 | +11.3% | earnings | Associated Press Finance | Compugen: Q4 Earnings Snapshot |
| 2026-03-02 | +11.3% | news | PR Newswire | Compugen Reports Fourth Quarter and Full Year 2025 Results |
| 2026-03-02 | +11.3% | news | Seeking Alpha | Compugen: Non-Dilutive Funding For Rilvegostomig Obtained And GS-0321 Advancement |
| 2026-03-02 | +11.3% | earnings | Seeking Alpha | Compugen Ltd. (CGEN) Q4 2025 Earnings Call Transcript |
| 2026-03-02 | +11.3% | earnings | Seeking Alpha | Compugen GAAP EPS of $0.60 beats by $0.55, revenue of $67.33M beats by $53.03M |
| 2026-03-02 | +11.3% | news | Seeking Alpha | Compugen: Non-Dilutive Funding For Rilvegostomig Obtained And GS-0321 Advancement (CGEN) - Seeking Alpha |
| 2026-03-02 | +11.3% | M&A | Stock Titan | AstraZeneca deal extends Compugen cash runway to 2029 after $65M payment - Stock Titan |
| 2024-11-11 | -9.9% | earnings | Seeking Alpha | Compugen Q3 2024 Earnings Preview |
| 2026-04-13 | +9.4% | expansion | MarketBeat | Compugen Highlights AI-Driven IO Pipeline, Key Trial Timelines and Big Pharma Partnerships at Needham Conference |
| 2026-04-13 | +9.4% | news | Stock Titan | Compugen (NASDAQ: CGEN) SVP exercises options, sells 3,125 shares under plan - Stock Titan |
| 2026-04-13 | +9.4% | news | Stock Titan | Levine Zurit sells 24,375 CGEN ordinary shares (CGEN) - Stock Titan |
| 2024-02-11 | +8.9% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2024-11-12 | -8.4% | earnings | Seeking Alpha | Compugen Ltd. (CGEN) Q3 2024 Earnings Call Transcript |
| 2024-11-12 | -8.4% | earnings | Seeking Alpha | Compugen GAAP EPS of $0.01 misses by $0.05, revenue of $17.13M misses by $0.54M |
| 2025-10-27 | -6.4% | news | Seeking Alpha | Compugen Stock: Runway Into 2027 But Expensive |
| 2025-10-27 | -6.4% | news | Seeking Alpha | Compugen Stock: Runway Into 2027 But Expensive (NASDAQ:CGEN) - Seeking Alpha |
| 2024-08-10 | -4.6% | earnings | Seeking Alpha | Compugen Ltd. (CGEN) Q2 2024 Earnings Call Transcript |
| 2023-06-10 | +4.4% | analyst | TradingView | CGEN Forecast — Price Target — Prediction for 2027 - TradingView |
| 2025-11-10 | +4.4% | earnings | Seeking Alpha | Compugen Ltd. (CGEN) Q3 2025 Earnings Call Transcript |
| 2025-11-10 | +4.4% | earnings | Seeking Alpha | Compugen GAAP EPS of -$0.07, revenue of $1.9M |
| 2026-04-03 | -4.0% | news | Stock Titan | Compugen (CGEN) SVP exercises stock options and sells 3,500 shares under 10b5-1 plan - Stock Titan |
| 2026-04-03 | -4.0% | executive | Stock Titan | Compugen (CGEN) CEO exercises options and sells 5,625 shares in 10b5-1 trade - Stock Titan |
| 2026-04-16 | -3.9% | news | Meyka | CGEN Insider Sells: Levine Zurit Disposes 2,000 Shares April 16, 2026 - Meyka |
| 2026-02-26 | +3.9% | earnings | Zacks | Kymera Therapeutics, Inc. (KYMR) Reports Q4 Loss, Misses Revenue Estimates |
| 2025-08-08 | +3.6% | news | Seeking Alpha | Compugen: Potential Best-In-Class Anti-PVRIG COM701 Shifts To Targeting PSOC Patients |
| 2025-04-25 | -3.5% | news | Stock Titan | CGEN Stock Price, News & Analysis - Stock Titan |
| 2025-05-25 | -3.5% | analyst | simplywall.st | Analysts Just Shaved Their Compugen Ltd. (NASDAQ:CGEN) Forecasts Dramatically - simplywall.st |
| 2025-04-09 | -3.1% | news | simplywall.st | Is There An Opportunity With Compugen Ltd.'s (NASDAQ:CGEN) 33% Undervaluation? - simplywall.st |
| 2026-02-17 | +2.4% | news | Stock Titan | Cancer immunotherapy company Compugen sets March 2 date for 2025 results - Stock Titan |
| 2026-03-04 | +2.4% | earnings | GuruFocus.com | Compugen Ltd (CGEN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... |
| 2026-04-22 | +2.2% | earnings | Cổng thông tin điện tử Tỉnh Sơn La | CGEN (Compugen Ltd. Ordinary Shares) posts 161% YoY Q4 2025 revenue growth and massive EPS beat over analyst estimates. - Earnings Preview - Cổng thông tin điện tử Tỉnh Sơn La |
| 2025-08-06 | -2.1% | earnings | Seeking Alpha | Compugen misses Q2 estimates |
| 2025-08-07 | +2.0% | news | Seeking Alpha | Compugen signals leadership transition and advances COM701 ovarian cancer trial with interim data targeted for 2026 |
| 2025-08-07 | +2.0% | earnings | Seeking Alpha | Compugen Ltd. (CGEN) Q2 2025 Earnings Call Transcript |
| 2026-02-19 | +1.9% | news | Stock Titan | Cancer immunotherapy firm Compugen to stream talks from two investor conferences - Stock Titan |
| 2026-03-30 | +1.8% | news | Stock Titan | Compugen (CGEN) SVP uses 10b5-1 plan to exercise options and sell shares - Stock Titan |
| 2025-12-17 | +1.7% | M&A | Seeking Alpha | Compugen rises on royalty deal with AstraZeneca |
| 2025-12-17 | +1.7% | M&A | Stock Titan | Cancer immunotherapy royalty deal brings biotech up to $90M in funding - Stock Titan |
| 2025-05-19 | +1.7% | earnings | Seeking Alpha | Compugen Ltd. (CGEN) Q1 2025 Earnings Call Transcript |
| 2025-05-19 | +1.7% | earnings | Seeking Alpha | Compugen GAAP EPS of -$0.08, revenue of $2.3M |
| 2025-05-13 | -1.5% | executive | Seeking Alpha | Compugen CEO Anat Cohen-Dayag to transition to executive chair |
| 2025-05-13 | -1.5% | news | Intellectia AI | CGEN Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI |
| 2026-04-02 | -1.5% | legal | Stock Titan | [144] COMPUGEN LTD SEC Filing - Stock Titan |
| 2025-10-07 | +0.9% | earnings | simplywall.st | There's No Escaping Compugen Ltd.'s (NASDAQ:CGEN) Muted Revenues Despite A 25% Share Price Rise - simplywall.st |
| 2025-05-14 | +0.9% | news | Intellectia AI | CGEN Forecast — Price Prediction for 2026. Should I Buy CGEN? - Intellectia AI |
| 2024-08-06 | -0.9% | earnings | Seeking Alpha | Compugen GAAP EPS of -$0.02, revenue of $6.7M |
| 2025-05-16 | +0.7% | earnings | Seeking Alpha | Compugen Q1 2025 Earnings Preview |
| 2026-04-15 | -0.7% | news | Stock Titan | Compugen (CGEN) SVP sells 3,125 shares under Rule 10b5-1 plan - Stock Titan |
| 2026-04-15 | -0.7% | news | Stock Titan | [Form 4] COMPUGEN LTD Insider Trading Activity - Stock Titan |
| 2026-04-15 | -0.7% | news | Stock Titan | CGEN (Nasdaq) Rule 144: 2,000-option shares to be sold; prior 26,375 sale - Stock Titan |
| 2026-04-15 | -0.7% | executive | Stock Titan | Compugen (CGEN) CEO exercises options and sells 5,000 shares under 10b5-1 plan - Stock Titan |
| 2026-04-15 | -0.7% | news | Stock Titan | Ophir Eran (CGEN) files to sell 5,000 Ordinary shares under option plan - Stock Titan |
| 2026-03-12 | +0.3% | earnings | Insider Monkey | Compugen Ltd. (CGEN) Reports Q4 Revenue of $67.3 Million vs. $1.5 Million Last Year |
| 2024-08-05 | +0.3% | earnings | Seeking Alpha | Compugen Q2 2024 Earnings Preview |
| 2025-08-05 | -0.3% | earnings | Seeking Alpha | Compugen Q2 2025 Earnings Preview |
| 2025-08-09 | +0.2% | analyst | Yahoo Finance | Need To Know: Analysts Just Made A Substantial Cut To Their Compugen Ltd. (NASDAQ:CGEN) Estimates - Yahoo Finance |
| 2025-11-07 | +0.2% | earnings | Seeking Alpha | Compugen Q3 2025 Earnings Preview |
| 2025-03-04 | +0.1% | earnings | Seeking Alpha | Compugen Ltd. (CGEN) Q4 2024 Earnings Call Transcript |
| 2025-03-04 | +0.1% | earnings | Seeking Alpha | Compugen GAAP EPS of -$0.07 misses by $0.14, revenue of $1.47M misses by $16M |
| 2025-02-18 | -0.1% | news | Seeking Alpha | Compugen: Immuno-Oncology Innovator Poised For A Comeback |